P596 Trough concentration of ustekinumab was a useful biomarker for the prediction of treatment-effects in patients with Crohn’s Diseases

Saved in:
Bibliographic Details
Published in:Journal of Crohn's and colitis 2021-05, Vol.15 (Supplement_1), p.S543-S543
Main Authors: Kato, S, Yamaga, N, Ishibashi, A, Kani, K, Yakabi, K, Nagoshi, S
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1873-9946
1876-4479
DOI:10.1093/ecco-jcc/jjab076.717